• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parexel Adds Two Locations in China

Parexel Adds Two Locations in China

May 27, 2010
CenterWatch Staff

Parexel has opened two new offices in China, increasing its presence in the Asia-Pacific region to 17 locations, in order to meet growing demand for clinical development and regulatory consulting services from drug sponsors looking for more opportunities to include China in global drug development strategies.

The global CRO recently opened offices in Chengdu and Guangzhou as part of the company’s focus on strengthening its presence and clinical development services in the Asia-Pacific region. In China, Parexel also has offices in Beijing and Shanghai as well as Kowloon, Hong Kong.

While Parexel does not typically report employee numbers by country, the CRO has about 1,600 employees throughout the Asia-Pacific region. The CRO has centers in other Asia-Pacific countries, including Australia, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand.

Parexel opened the new offices at a time pharmaceutical companies are increasingly interested in China as an end market for their products. China is positioned to become the fifth largest pharmaceutical market this year and is expected to reach approximately $47 billion in size by 2013.

As a result, clinical research growth is accelerating in the region and China has become an attractive market for biopharmaceutical development. “Foreseeing China’s potential for clients, Parexel was a pioneer in establishing a firm foundation for clinical development in the country. Further expansion of expert resources in Asia is designed to meet client demand for greater opportunities to include China in their global drug development strategies and obtain China market registration,” said Josef von Rickenbach, chairman and CEO of Parexel.

Parexel is one of several global CROs developing operations in the Asia-Pacific region, with particular focus on China, to help drug sponsors take advantage of the many opportunities the region offers. Access to large patient populations, low costs, an expanding medical infrastructure as well as the opportunity to market drugs in the region have driven rapid growth of clinical research in the area. “China is attractive for global clinical development activities for several reasons, including significant savings on overall clinical trial cost,” said Mark Goldberg, M.D., chief operating officer of Parexel. “The cost of conducting trials in China can be one-third of the total costs in the U.S. due to lower per patient costs.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing